Altogether, our results suggest that the anti-inflammatory role of ATO in colitis seems broadly dependent on the PPAR-α effects and colonic PPAR-α expression is a potential candidate to predict the outcome of IBD treatment. Here, PPARA is linked to inflammatory bowel disease.